2022 annual financial data

Adaptive Biotechnologies 2022 Financial results

Direct answer

Revenue was 185,308,000 USD.

Operating income was -200,186,000 USD and net income was -200,191,000 USD.
Operating cash flow was -183,945,000 USD.

Get free Adaptive Biotechnologies email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
185,308,000 USD
Operating income
-200,186,000 USD
Net income
-200,191,000 USD
Operating cash flow
-183,945,000 USD